Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in NUVB — Nuvation Bio Inc.

CIK 1362033 LONDON, X0
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,144,020
-$982,927 QoQ
Shares Held
201,412
-59.4% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#79
of 242 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. NUVB ranks #29 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 187,337 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in NUVB

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,144,020 201,412
2026-03-31 $2,126,947 495,792
2025-12-31 $126,434 14,111
2025-09-30 $3,830,210 1,035,192
2025-06-30 $3,172,887 1,627,122
2025-03-31 $1,163,451 661,052
2024-12-31 $644,392 242,253
2024-09-30 $171,594 74,932
2023-12-31 $64,591 42,776
2023-09-30 $308,595 230,295
2023-06-30 $498,033 276,685
2023-03-31 $528,816 318,564
2022-12-31 $475,278 247,541
2022-09-30 $444,364 198,377
2022-06-30 $112,564 34,742